New study tracks heart valve damage from pacemaker leads

NCT ID NCT07342036

Recruiting now Knowledge-focused Sponsor: Hazem Omran Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to measure how often a heart valve leak (tricuspid regurgitation) develops or worsens after getting a pacemaker or defibrillator with a lead that crosses the valve. About 200 adults who need their first device will have heart ultrasounds before and after the procedure, plus checkups at 6 and 12 months. The goal is to better understand this complication and improve future care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC CONDUCTION DISORDER REQUIRING PACEMAKER, ICD, OR CRT IMPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart conduction disease impulse control disorder tricuspid valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ICD LEFT BUNDLE BRANCH AREA PACING PACEMAKER TRICUSPID VALVE REGURGITATION

Contacts and locations

Locations

Herz- und Diabeteszentrum NRW
RECRUITING

Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.